Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
210 articles
7 of 21
Three new DiGAs. Click, Better and Neuroglee Trials.
10.14.22
5
min. Read
UnitedHealth’s Medicaid-Medicare plan covers Pear. Trials
10.07.22
6
min. Read
Projecting Medicare, Medicaid spend on prescription digital therapeutics.
9.30.22
10
min. Read
AppleVR Alzheimer’s. Mahana freemium. Trials
9.23.22
6
min. Read
Big Health RCT suggests Sleepio heading to FDA? Trials
9.16.22
8
min. Read
Apple hints about future FDA submissions. Trial updates
9.09.22
8
min. Read
Mahana’s freemium prescription digital therapeutic.
9.02.22
6
min. Read
Akili average sales price drops. Clinical trial updates
8.26.22
9
min. Read
Pear lowers ’22 revenue target. VA prices deprexis. Trials
8.12.22
6
min. Read
Product revenue vs investment dollars for prescription digital therapeutics. Trials updates
8.05.22
8
min. Read
1 of 21